Analysis of Survival Modification by Furosemide Use in a Cohort of Hospitalized COVID-19 Patients with Severe or Critical Disease in Mexico: Due to Its Chemical Structure, Furosemide Is More than Just a Diuretic

• Egile Nagusiak: Janet Diaz-Martinez (Egilea), Wayne Kotzker (Egilea), Martha A. Mendoza-Hernandez (Egilea), Rajdeep S. Gadh (Egilea), Gustavo A. Hernandez-Fuentes (Egilea), Andrew Bañuelos (Egilea), José Guzmán-Esquivel (Egilea), Angelina Hong (Egilea), Osiris G. Delgado-Enciso (Egilea), Elizabeth Geyer-Roberts (Egilea), Margarita L. Martinez-Fierro (Egilea), Iram P. Rodriguez-Sanchez (Egilea), Idalia Garza-Veloz (Egilea), Luis M. Canseco-Ávila (Egilea), Ivan Delgado-Enciso (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

In the ongoing fight against Coronavirus Disease 2019 (COVID-19), researchers are exploring potential treatments to improve outcomes, especially in severe cases. This includes investigating the repurposing of existing medications, such as furosemide, which is widely available. This study aimed to ev...